Attached files
| file | filename |
|---|---|
| S-1/A - AMENDMENT NO. 1 TO FORM S-1 - AGIOS PHARMACEUTICALS, INC. | d538215ds1a.htm |
| EX-3.3 - EX-3.3 - AGIOS PHARMACEUTICALS, INC. | d538215dex33.htm |
| EX-4.1 - EX4.1 - AGIOS PHARMACEUTICALS, INC. | d538215dex41.htm |
| EX-3.4 - EX-3.4 - AGIOS PHARMACEUTICALS, INC. | d538215dex34.htm |
| EX-10.4 - EX-10.4 - AGIOS PHARMACEUTICALS, INC. | d538215dex104.htm |
| EX-10.7 - EX-10.7 - AGIOS PHARMACEUTICALS, INC. | d538215dex107.htm |
| EX-10.5 - EX-10.5 - AGIOS PHARMACEUTICALS, INC. | d538215dex105.htm |
| EX-10.6 - EX-10.6 - AGIOS PHARMACEUTICALS, INC. | d538215dex106.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated May 23, 2013 in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-189216) and related Prospectus of Agios Pharmaceuticals, Inc.
/s/ Ernst & Young LLP
Boston, Massachusetts
June 21, 2013